Medicinal composition for treating atherosclerosis and application

A technology of atherosclerosis and composition, which is applied in the field of medicine, can solve problems such as unsatisfactory effects, and achieve the effect of inhibiting blood lipid elevation

Inactive Publication Date: 2017-06-30
XINXIANG MEDICAL UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

General prevention is mainly based on reasonable diet, physica

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition for treating atherosclerosis and application
  • Medicinal composition for treating atherosclerosis and application
  • Medicinal composition for treating atherosclerosis and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A pharmaceutical composition for treating atherosclerosis, the pharmaceutical composition comprises the following raw materials prepared by weight: 0.9 parts of (+)-limonene, 7 parts of γ-ionone, and 102 parts of ethyl maltol.

Embodiment 2

[0036] A pharmaceutical composition for treating atherosclerosis, the pharmaceutical composition comprises the following raw materials prepared by weight: 101 parts of (+)-limonene, 7 parts of γ-ionone, and 9 parts of ethyl maltol.

Embodiment 3

[0038] A pharmaceutical composition for treating atherosclerosis, the pharmaceutical composition comprises the following raw materials prepared by weight: 102 parts of (+)-limonene, 101 parts of γ-ionone, and 9 parts of ethyl maltol.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicinal composition for treating atherosclerosis and application. The medicinal composition is prepared from the following raw materials: (+)-limonene, gamma-ionone and ethyl maltol. The medicinal composition has the advantages of significant inhibition on blood lipid increase of a rat fed with a high-fat diet, capability of effectively treating the atherosclerosis, an obvious effect, stable quality control, and suitability for long-term use of a patient.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition and application for treating atherosclerosis. Background technique [0002] Atherosclerosis is a kind of arteriosclerosis, which mainly occurs in the intima of large and medium arteries, and yellow atherosclerotic plaques containing cholesterol and fat-like substances appear, which are mostly caused by fat metabolism disorders and neurovascular dysfunction. Often lead to thrombosis, blood supply disorders and so on. The incidence of atherosclerosis is more common in men over the age of 40 and postmenopausal women. The disease is often accompanied by hypertension, hypercholesterolemia or diabetes. Atherosclerosis is a common disease, frequently-occurring disease, one of the diseases with high mortality and disability rate, which seriously endangers the life and health of human beings. . [0003] At present, there is no better drug for ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/351A61K31/015A61K31/12A61P3/06A61P9/10
CPCA61K31/351A61K31/015A61K31/12A61K2300/00
Inventor 郑斌尹志奎王霄杨丽娟申彪孙祥德王双喜
Owner XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap